Adefovir - Key patent, SPC, and data exclusivity expiry (44 country coverage)

Aarkstore announce a new report "Adefovir - Key patent, SPC, and data exclusivity expiry (44 country coverage)" through its vast collection of market research report.

Online PR News – 25-February-2011 – – Aarkstore announce a new report "Adefovir - Key patent, SPC, and data exclusivity expiry (44 country coverage)" through its vast collection of market research report.

Pipeline Selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players.

This Pipeline Selector report covers Adefovir
Adefovir indications: Treatment of chronic hepatitis B with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.
Adefovir innovator: Gilead (Hepsera)

Examples of information found in this online report include:
# Includes key patent publications for 44 countries (see list below)
# Contains SPC protection for every EU state plus patent term extensions in other countries
# Data exclusivity calculated on a country by country basis
# Summary of dosage forms, strengths, indications and active ingredient forms of the brand product
# DMF & Paragraph IV filings
# Litigation alerts
# Marketing authorisation holders in selected territories
# Patent risk analysis via graphical display of data from patent filings
# Hyper-linking to crucial patent documents and national registries enabling data verification

The Key Patent Indicator enables easy identification of key patent, SPC and data protection expiry information covering 44 countries, including extension details (SPC and national law) for 30 European countries, Australia, Israel, Japan and the USA. (also available with 44 country coverage):

Pipeline Selector 44 Country Coverage:

Country Region Extensions
Australia Asia-Pacific S70
Canada Americas N/A
USA Americas S156
Germany Western Europe SPC
Great Britain Western Europe SPCS
France Western Europe NAT/SPC
Spain Western Europe SPC
South Africa Africa N/A
China Asia-Pacific N/A
Japan Asia-Pacific S67
New Zealand Asia-Pacific N/A
Bosnia & Herzegovina Balkan N/A
Bulgaria Balkan SPC
Croatia Balkan N/A
Romania Balkan SPC
Slovenia Balkan NAT/SPC
Estonia Baltic NAT/SPC
Lithuania Baltic NAT/SPC
Latvia Baltic NAT/SPC
Czech Republic Central Europe NAT/SPC

For more information, please contact :
http://www.aarkstore.com/reports/Adefovir-Key-patent-SPC-and-data-exclusivity-expiry-44-country-coverage--91048.html

Bookmarkse-mailGoogledel.icio.usStumbleUponSlashdotFurlDiggTechnoratiYahooMyWebBlinkListSpurlRawSugarWists
 
 
Contact Information
Jessica

+918149852585